NCT00125983View on ClinicalTrials.gov

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2007

Conditions
HIV InfectionsPregnancy
Interventions
DRUG

Lopinavir/ritonavir

DRUG

Ortho Novum 1/35

DRUG

Ortho Evra

Trial Locations (9)

10003

Beth Israel Med. Ctr., ACTU, New York

10021

Weill Med. College of Cornell Univ., The Cornell CTU, New York

90033

Usc La Nichd Crs, Los Angeles

90033-1079

USC CRS, Los Angeles

Unknown

University of Colorado Hospital CRS, Aurora

Pitt CRS, Pittsburgh

San Juan City Hosp. PR NICHD CRS, San Juan

96816-2396

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

46202-5250

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

All Listed Sponsors
collaborator

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00125983 - Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women | Biotech Hunter | Biotech Hunter